Concomitant difluoromethylornithine/ sulindac chemoprevention of colorectal adenomas: a major clinical advance

Michael Sporn and Waun Ki Hong

Combining two drugs, i.e. difluoromethylornithine and sulindac, at low doses has been shown, for the first time, to provide both great efficacy and great safety for clinical colon cancer prevention.

Download full article

Be the first to comment

Leave a Reply

Your email address will not be published.